Plasma γ-glutamyltransferase, cysteinyl-glycine, and oxidized low-density lipoprotein: A pathway associated with myocardial infarction risk?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 10, 2010, Pages 2053-2058

  Drogan, Dagmar ^a   Weikert, Cornelia ^a   Dierkes, Jutta ^b,c   Klipstein Grobusch, Kerstin ^a   Buijsse, Brian ^a   Möhlig, Matthias ^a,d   Pfeiffer, Andreas F H ^a,d   Pischon, Tobias ^a   Spranger, Joachim ^a,d   Boeing, Heiner ^a,e  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

glutamyltransferase; cysteinyl glycine; myocardial infarction; oxidized LDL; prospective study

Indexed keywords

CYSTEINYLGLYCINE; GAMMA GLUTAMYLTRANSFERASE; OXIDIZED LOW DENSITY LIPOPROTEIN; DIPEPTIDE; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AMINO ACID ANALYSIS; ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; COHORT ANALYSIS; GERMANY; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; DIPEPTIDES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GERMANY; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77957712075     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.209346     Document Type: Article

References (36)

1. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2007; 27:2729-2735.
2. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Fra-mingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:127-133.
3. Lee DH, Buijsse B, Steffen L, Holtzman J, Luepker R, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Car-diovasc Prev Rehabil. 2009;16:16-20.
4. Strasak AM, Kelleher CC, Klenk J, Brant LJ, Ruttmann E, Rapp K, Concin H, Diem G, Pfeiffer KP, Ulmer H. Longitudinal change in serum gamma- glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol. 2008;28:1857-1865.
5. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, Dominici S, Comporti M, Pompella A. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation: a potential mechanism in atherosclerosis. J Investig Med. 1999;47:151-160.
6. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005;112:2078-2080.
7. Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany: European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999;43:205-215.
8. Bergmann MM, Bussas U, Boeing H. Follow-up procedures in EPIC-Germany: data quality aspects: European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999;43:225-234.
9. WHO MONICA Project. MONICA manual, part IV: event registration. Section 1: coronary event registration data component. 1999. Available at http://www.ktl.fi/publications/monica/manual/part4/iv-2.htm. Accessed December 8, 2009.
10. Kroke A, Bergmann MM, Lotze G, Jeckel A, Klipstein-Grobusch K, Boeing H. Measures of quality control in the German component of the EPIC study: European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999;43:216-224.
11. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproduc-ibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project: European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26:S59-S70.
12. Dierkes J, Jeckel A, Ambrosch A, Westphal S, Luley C, Boeing H. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study. Metabolism. 2001;50:640-645.
13. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. BioMetrika. 1986;73:1-11.
14. Chen C, Wang H, Snapinn SM. Proportion of treatment effect (PTE) explained by a surrogate marker. Stat Med. 2003;22:3449-3459.
15. Fieller EC. The biological standardization of insulin. J R Stat Soc. 1940; 7(suppl):1-15.
16. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, Tuomilehto J. Serum gamma-glutamyltransferase predicts non-fatal myo-cardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J. 2006;27:2170-2176.
17. Meisinger C, Doring A, Schneider A, Lowel H. Serum gamma- glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis. 2006;189:297-302.
18. Hozawa A, Okamura T, Kadowaki T, Murakami Y, Nakamura K, Hayakawa T, Kita Y, Nakamura Y, Okayama A, Ueshima H. Gamma-glutamyltransferase predicts cardiovascular death among Japanese women. Atherosclerosis. 2007;194:498-504.
19. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130-2137.
20. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995;142:699-708.
21. Lee DH, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis. 2005;178:327-330.
22. Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, Glauber M, Pompella A, Paolicchi A. Gamma-glutamyltransferase activity in human atherosclerotic plaques: biochemical similarities with the circulating enzyme. Atherosclerosis. 2009;202:119-127.
23. Mendis S, Athauda SB, Takashi K. Association between hyperhomocys- teinemia and ischemic heart disease in Sri Lankans. Int J Cardiol. 1997; 62:221-225.
24. Ozkan Y, Ozkan E, Simsek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol. 2002;82:269-277.
25. Zinellu A, Lepedda A Jr, Sotgia S, Zinellu E, Scanu B, Turrini F, Spirito R, Deiana L, Formato M, Carru C. Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques. Clin Biochem. 2009;42:796-801.
26. Ueland PM, Mansoor MA, Guttormsen AB, Muller F, Aukrust P, Refsum H, Svardal AM. Reduced, oxidized and protein-bound forms of homo-cysteine and other aminothiols in plasma comprise the redox thiol status: a possible element of the extracellular antioxidant defense system. J Nutr. 1996;126:1281S-1284S.
27. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, Nagahiro S. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol. 2002;22:1649-1654.
28. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes. 2004;53: 1068-1073.
29. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation. 2005;112:651-657.
30. Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among US men and women? J Am Coll Cardiol. 2006;48:973-979.
31. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38:535-539.
32. Lee DH, Jacobs DR Jr. Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants? Free Radic Res. 2009;43: 533-537.
33. Sedda V, De Chiara B, Parolini M, Caruso R, Campolo J, Cighetti G, De Maria R, Sachero A, Donato L, Parodi O. Plasma glutathione levels are independently associated with gamma-glutamyltransferase activity in subjects with cardiovascular risk factors. Free Radic Res. 2008;42:135-141.
34. Back M. Leukotriene signaling in atherosclerosis and ischemia. Car-diovasc Drugs Ther. 2009;23:41-48.
35. Grundy SM. Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2007;27:4-7.
36. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation. 2008;118: 2555-2562.